This new class of GLP-1 weight loss drugs may feel like a miracle, but it still takes effort from you for these meds to work safely and effectively.

Mounjaro side effect explained as more than 220,000 Brits are expected to receive the drug over the next three years ...

GLP-1 receptor agonist drugs like Ozempic help people manage type 2 diabetes. Foods like Greek yogurt and avocados can't do ...

Binge eating disorder is strongly associated with weight gain and obesity, though not all individuals with obesity have BED.

Kenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 ...

People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

This new drug is a jab at Ozempic. Tirzepatide, a weekly injectable that rivals celebrity-favorite Wegovy, is one step closer to approval for weight loss by the Food and Drug Administration after ...

Diabetes drug Tirzepatide, which is shown to be more effective than Wegovy and Ozempic, is likely to be approved by the Food and Drug Administration for weight loss in 2023 and is expected to be ...

Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...

Tirzepatide targets both the GLP 1 and the GIP receptor agonist, ... Both Ozempic and Mounjaro are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes, ...

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...